The settlement is likely to boost Purdue’s effort to move past claims it helped spark a public-health crisis over opioids with its marketing of OxyContin. Photo: TNS The settlement is likely to boost Purdue’s effort to move past claims it helped spark a public-health crisis over opioids with its marketing of OxyContin. Photo: TNS
The settlement is likely to boost Purdue’s effort to move past claims it helped spark a public-health crisis over opioids with its marketing of OxyContin. Photo: TNS

OxyContin maker Purdue Pharma to plead guilty, pay US$8.3 billion over opioids

  • Company’s marketing of addictive painkiller allegedly helped spark opioid crisis, which led to more than 200,000 US overdose deaths
  • Purdue, owned by members of billionaire Sackler family, still faces thousands of claims by local and state officials

Topic |   Fentanyl and other opioids
The settlement is likely to boost Purdue’s effort to move past claims it helped spark a public-health crisis over opioids with its marketing of OxyContin. Photo: TNS The settlement is likely to boost Purdue’s effort to move past claims it helped spark a public-health crisis over opioids with its marketing of OxyContin. Photo: TNS
The settlement is likely to boost Purdue’s effort to move past claims it helped spark a public-health crisis over opioids with its marketing of OxyContin. Photo: TNS
READ FULL ARTICLE